Table of Contents Executive Summary 1 Industry Overview of End-Stage Renal Disease (ESRD) Drugs 1.1 Definition of End-Stage Renal Disease (ESRD) Drugs 1.2 End-Stage Renal Disease (ESRD) Drugs Segment by Type 1.2.1 Global End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Calcium Succinate 1.2.3 Mk-3866 1.2.4 Pacritinib 1.2.5 Sanguinate 1.2.6 Tesidolumab 1.2.7 Others 1.3 End-Stage Renal Disease (ESRD) Drugs Segment by Applications 1.3.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 ICU 1.3.5 Others 1.4 Global End-Stage Renal Disease (ESRD) Drugs Overall Market 1.4.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue (2014-2025) 1.4.2 Global End-Stage Renal Disease (ESRD) Drugs Production (2014-2025) 1.4.3 North America End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025) 1.4.4 Europe End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025) 1.4.5 China End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025) 1.4.6 Japan End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025) 1.4.8 India End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of End-Stage Renal Disease (ESRD) Drugs 2.3 Manufacturing Process Analysis of End-Stage Renal Disease (ESRD) Drugs 2.4 Industry Chain Structure of End-Stage Renal Disease (ESRD) Drugs 3 Development and Manufacturing Plants Analysis of End-Stage Renal Disease (ESRD) Drugs 3.1 Capacity and Commercial Production Date 3.2 Global End-Stage Renal Disease (ESRD) Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of End-Stage Renal Disease (ESRD) Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 End-Stage Renal Disease (ESRD) Drugs Production and Capacity Analysis 4.2 End-Stage Renal Disease (ESRD) Drugs Revenue Analysis 4.3 End-Stage Renal Disease (ESRD) Drugs Price Analysis 4.4 Market Concentration Degree 5 End-Stage Renal Disease (ESRD) Drugs Regional Market Analysis 5.1 End-Stage Renal Disease (ESRD) Drugs Production by Regions 5.1.1 Global End-Stage Renal Disease (ESRD) Drugs Production by Regions 5.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Regions 5.2 End-Stage Renal Disease (ESRD) Drugs Consumption by Regions 5.3 North America End-Stage Renal Disease (ESRD) Drugs Market Analysis 5.3.1 North America End-Stage Renal Disease (ESRD) Drugs Production 5.3.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America End-Stage Renal Disease (ESRD) Drugs Import and Export 5.4 Europe End-Stage Renal Disease (ESRD) Drugs Market Analysis 5.4.1 Europe End-Stage Renal Disease (ESRD) Drugs Production 5.4.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe End-Stage Renal Disease (ESRD) Drugs Import and Export 5.5 China End-Stage Renal Disease (ESRD) Drugs Market Analysis 5.5.1 China End-Stage Renal Disease (ESRD) Drugs Production 5.5.2 China End-Stage Renal Disease (ESRD) Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China End-Stage Renal Disease (ESRD) Drugs Import and Export 5.6 Japan End-Stage Renal Disease (ESRD) Drugs Market Analysis 5.6.1 Japan End-Stage Renal Disease (ESRD) Drugs Production 5.6.2 Japan End-Stage Renal Disease (ESRD) Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan End-Stage Renal Disease (ESRD) Drugs Import and Export 5.7 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Market Analysis 5.7.1 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Production 5.7.2 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Import and Export 5.8 India End-Stage Renal Disease (ESRD) Drugs Market Analysis 5.8.1 India End-Stage Renal Disease (ESRD) Drugs Production 5.8.2 India End-Stage Renal Disease (ESRD) Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India End-Stage Renal Disease (ESRD) Drugs Import and Export 6 End-Stage Renal Disease (ESRD) Drugs Segment Market Analysis (by Type) 6.1 Global End-Stage Renal Disease (ESRD) Drugs Production by Type 6.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type 6.3 End-Stage Renal Disease (ESRD) Drugs Price by Type 7 End-Stage Renal Disease (ESRD) Drugs Segment Market Analysis (by Application) 7.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption by Application 7.2 Global End-Stage Renal Disease (ESRD) Drugs Consumption Market Share by Application (2014-2019) 8 End-Stage Renal Disease (ESRD) Drugs Major Manufacturers Analysis 8.1 CTI BioPharma Corp 8.1.1 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served 8.1.2 CTI BioPharma Corp Product Introduction, Application and Specification 8.1.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Merck & Co Inc 8.2.1 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served 8.2.2 Merck & Co Inc Product Introduction, Application and Specification 8.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Novartis AG 8.3.1 Novartis AG End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served 8.3.2 Novartis AG Product Introduction, Application and Specification 8.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Prolong Pharmaceuticals LLC 8.4.1 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served 8.4.2 Prolong Pharmaceuticals LLC Product Introduction, Application and Specification 8.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 VESSL Therapeutics Ltd 8.5.1 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served 8.5.2 VESSL Therapeutics Ltd Product Introduction, Application and Specification 8.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 9 Development Trend of Analysis of End-Stage Renal Disease (ESRD) Drugs Market 9.1 Global End-Stage Renal Disease (ESRD) Drugs Market Trend Analysis 9.1.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 End-Stage Renal Disease (ESRD) Drugs Regional Market Trend 9.2.1 North America End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025 9.2.2 Europe End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025 9.2.3 China End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025 9.2.4 Japan End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025 9.2.5 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025 9.2.6 India End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025 9.3 End-Stage Renal Disease (ESRD) Drugs Market Trend (Product Type) 9.4 End-Stage Renal Disease (ESRD) Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 End-Stage Renal Disease (ESRD) Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of End-Stage Renal Disease (ESRD) Drugs Table Global End-Stage Renal Disease (ESRD) Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global End-Stage Renal Disease (ESRD) Drugs Production Market Share by Types in 2018 Figure Calcium Succinate Product Picture Figure Mk-3866 Product Picture Figure Pacritinib Product Picture Figure Sanguinate Product Picture Figure Tesidolumab Product Picture Figure Others Product Picture Table Global End-Stage Renal Disease (ESRD) Drugs Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global End-Stage Renal Disease (ESRD) Drugs Consumption Market Share by Applications in 2018 Figure Hospital Figure Clinic Figure ICU Figure Others Figure Global End-Stage Renal Disease (ESRD) Drugs Revenue (Million USD) (2014-2025) Figure Global End-Stage Renal Disease (ESRD) Drugs Production (K Pcs) (2014-2025) Figure North America End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025) Figure Europe End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025) Figure China End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025) Figure Japan End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025) Figure India End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025) Table End-Stage Renal Disease (ESRD) Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of End-Stage Renal Disease (ESRD) Drugs in 2018 Figure Manufacturing Process Analysis of End-Stage Renal Disease (ESRD) Drugs Figure Industry Chain Structure of End-Stage Renal Disease (ESRD) Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global End-Stage Renal Disease (ESRD) Drugs Manufacturing Plants Distribution Table End-Stage Renal Disease (ESRD) Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table End-Stage Renal Disease (ESRD) Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019) Table End-Stage Renal Disease (ESRD) Drugs Production (K Pcs) of Major Manufacturers (2014-2019) Table End-Stage Renal Disease (ESRD) Drugs Production Market Share of Major Manufacturers (2014-2019) Figure End-Stage Renal Disease (ESRD) Drugs Production Share by Manufacturers in 2018 Table End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table End-Stage Renal Disease (ESRD) Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure End-Stage Renal Disease (ESRD) Drugs Revenue Share by Manufacturers in 2018 Table End-Stage Renal Disease (ESRD) Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global End-Stage Renal Disease (ESRD) Drugs Production by Regions 2014-2019 (K Pcs) Table Global End-Stage Renal Disease (ESRD) Drugs Production Market Share by Regions 2014-2019 Figure Global End-Stage Renal Disease (ESRD) Drugs Production Market Share by Regions in 2018 Table Global End-Stage Renal Disease (ESRD) Drugs Revenue by Regions 2014-2019 (Million USD) Table Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Regions 2014-2019 Figure Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Regions in 2018 Table Global End-Stage Renal Disease (ESRD) Drugs Consumption by Regions 2014-2019 (K Pcs) Table Global End-Stage Renal Disease (ESRD) Drugs Consumption Market Share by Regions 2014-2019 Figure North America End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs) Figure North America End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs) Figure Europe End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs) Figure Europe End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs) Figure China End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs) Figure China End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs) Figure Japan End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs) Figure Japan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs) Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs) Figure India End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs) Figure India End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs) Figure Global Consumption End-Stage Renal Disease (ESRD) Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) End-Stage Renal Disease (ESRD) Drugs Market Share by Application (2014-2019) Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production Growth Rate (2014-2019) Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production Market Share (2014-2019) Figure CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Revenue Market Share (2014-2019) Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Main Business and Markets Served Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production Growth Rate (2014-2019) Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production Market Share (2014-2019) Figure Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Revenue Market Share (2014-2019) Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Main Business and Markets Served Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Production Growth Rate (2014-2019) Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Production Market Share (2014-2019) Figure Novartis AG End-Stage Renal Disease (ESRD) Drugs Revenue Market Share (2014-2019) Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Main Business and Markets Served Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production Growth Rate (2014-2019) Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production Market Share (2014-2019) Figure Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Revenue Market Share (2014-2019) Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Main Business and Markets Served Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production Growth Rate (2014-2019) Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production Market Share (2014-2019) Figure VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Revenue Market Share (2014-2019) Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Main Business and Markets Served Figure Global End-Stage Renal Disease (ESRD) Drugs Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global End-Stage Renal Disease (ESRD) Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global End-Stage Renal Disease (ESRD) Drugs Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of End-Stage Renal Disease (ESRD) Drugs by Type (2019-2025) Table Global Consumption (K Pcs) of End-Stage Renal Disease (ESRD) Drugs by Application (2019-2025) Table End-Stage Renal Disease (ESRD) Drugs Distributors List Table End-Stage Renal Disease (ESRD) Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

CTI BioPharma Corp Merck & Co Inc Novartis AG Prolong Pharmaceuticals LLC VESSL Therapeutics Ltd